Pulse Biosciences, Inc. (PLSE) Stock Overview
Explore Pulse Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Pulse Biosciences, Inc. (PLSE)
Key Financials
Key Financials
Market Cap
3.3B
P/E Ratio
-40.80
EPS (TTM)
$-1.18
ROE
-0.94%
PLSE Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Pulse Biosciences, Inc. (NASDAQ: PLSE) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Pulse Biosciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PLSE on the NASDAQ shows an RSI of 77.34, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $26.52 for the NASDAQ listing.
Key metrics behind Pulse Biosciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -40.80 and a market capitalization of 3.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PLSE on the NASDAQ.